Close
ACHEMA MIDDLE EAST 2026

Pharma Packaging Market In Europe To Hit $35bn Come 2028

As per a report furnished by Arizton, the pharma packaging and labelling market across Europe is expected to reach $35.78 billion by 2028. This particular segment in Europe,...

Prominent Pharma Antitrust Lawsuits Over The Last Decade

Although one must have heard of tech giants such as Microsoft, Apple, as well as Meta getting caught up in certain antitrust scandals, big...

Xtandi Clones By Sun Pharma – Astellas-Pfizer Settle Case

As per findings pertaining to court filings, Astellas Pharma Inc. and Pfizer Inc. have gone on to reach a settlement in their lawsuit against...

EUGC Sets Last Pin On Pharma Reverse Payment Patent Deals

On October 18, 2023, the General Court of the European Union issued a judgement wherein it went on to reject the appeal made by...

US Patent Law Suit For Actemra Solved Between Roche & Biogen

Based on a filing on October 23 in Massachusetts federal court, Roche, the Swiss pharmaceutical giant, has reached a settlement in a patent lawsuit...

IP Waivers, Pathogen Sharing Benefits In Draft Pandemic Deal

The draft pandemic accord, which was sent to member states of the World Health Organisation by the Intergovernmental Negotiating Body recently, includes several important...

Innovation Can Grow When Big Pharma & Big Tech Collaborate

Big tech along with Big Pharma have gone on to play a crucial role in elevating standards of living as well as shaping the modern age. Over...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...